ReviewCancers2022
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond.
Axel de Bernardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it
ReviewCancers2022
Axel de Bernardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.